Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:42 PM
Ignite Modification Date:
2025-12-24 @ 4:42 PM
NCT ID:
NCT04785066
Eligibility Criteria:
Inclusion Criteria:
* Ischemic stroke by proximal intracranial occlusion (internal carotid artery, middle cerebral artery in its M1 or M2 segment) isolated from the anterior circulation eligible for cerebral thrombectomy.
* Transferred to the NRI block for a cerebral thrombectomy.
* Treated by thrombolysis intravenous (Aleplase or Tenecteplase) as recommanded by European stroke organisation
* With DWI-ASPECT score\>5 to MRI
Exclusion Criteria:
* Pregnant or breastfeeding woman
* Known allergy to Dornase alfa or one of its excipients.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04785066
Study Brief:
Protocol Section:
NCT04785066